Literature DB >> 21464333

Pharmacologic specificity of nicotinic receptor-mediated relaxation of muscarinic receptor precontracted human gastric clasp and sling muscle fibers within the gastroesophageal junction.

Alan S Braverman1, Anil K Vegesna, Larry S Miller, Mary F Barbe, Mansoor Tiwana, Kashif Hussain, Michael R Ruggieri.   

Abstract

Relaxation of gastric clasp and sling muscle fibers is involved the transient lower esophageal sphincter relaxations underlying the pathophysiology of gastroesophageal reflux disease (GERD). These fibers do not contribute tone to the high-pressure zone in GERD patients, indicating their role in pathophysiology. This study identifies some mediators of the nicotine-induced relaxation of muscarinic receptor precontracted gastric clasp and sling fibers. Muscle strips from organ donors precontracted with bethanechol were relaxed with nicotine and then rechallenged after washing and adding inhibitors tetrodotoxin (TTX), the nitric-oxide synthase inhibitor L-nitro-arginine methyl ester (L-NAME), the β-adrenoceptor antagonist propranolol, the glycine receptor antagonist strychnine or ginkgolide B, and the GABA(A) receptor antagonist bicuculline or 2-(3-carboxypropyl)-3-amino-6-(4 methoxyphenyl)pyridazinium bromide [(gabazine) SR95531]. TTX only inhibited clasp fiber relaxations. L-NAME and propranolol inhibited, and ginkgolide B was ineffective in both. SR95531 was ineffective in clasp fibers and partially effective in sling fibers. Strychnine and bicuculline prevented relaxations with low potency, indicating actions not on glycine or GABA(A) receptors but more consistent with nicotinic receptor blockade. Bethanechol-precontracted fibers were relaxed by the nitric oxide donor S-nitroso-N-acetyl-DL-penicillamine and by the β-adrenergic agonist isoproterenol (clasp fibers only) but not by the glycine receptor agonist taurine or glycine or the GABA(A) agonist muscimol. These data indicate that nicotinic receptor activation mediates relaxation via release of nitric oxide in clasp and sling fibers, norepinephrine acting on β-adrenoceptors in clasp fibers, and GABA acting on GABA(A) receptors in sling fibers. Agents that selectively prevent these relaxations may be useful in the treatment of GERD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464333      PMCID: PMC3126643          DOI: 10.1124/jpet.110.177097

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  44 in total

1.  Non-adrenergic non-cholinergic neuron stimulation in the cat lower esophageal sphincter.

Authors:  N Kortezova; Z Mizhorkova; E Milusheva; G Varga; E S Vizi; M Papasova
Journal:  Eur J Pharmacol       Date:  1996-05-23       Impact factor: 4.432

2.  Regional differences in cholinergic activity of muscle fibers from the human gastroesophageal junction.

Authors:  H G Preiksaitis; N E Diamant
Journal:  Am J Physiol       Date:  1997-06

Review 3.  Anatomy and physiology of the gastroesophageal junction.

Authors:  P J Kahrilas
Journal:  Gastroenterol Clin North Am       Date:  1997-09       Impact factor: 3.806

4.  Effects of postganglionic nerve stimulation in oesophageal achalasia: an in vitro study.

Authors:  A Tłottrup; A Forman; P Funch-Jensen; U Raundahl; K E Andersson
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 5.  The lower oesophageal sphincter.

Authors:  G E Boeckxstaens
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

6.  Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter.

Authors:  H J Stein; D Liebermann-Meffert; T R DeMeester; J R Siewert
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

7.  (+)-Hydrastine, a potent competitive antagonist at mammalian GABAA receptors.

Authors:  J H Huang; G A Johnston
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine.

Authors:  E X Albuquerque; E F Pereira; M F Braga; H Matsubayashi; M Alkondon
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

9.  An in vitro study of the relationship between GABA receptor function and propulsive motility in the distal colon of the rabbit.

Authors:  M Tonini; A Crema; G M Frigo; C A Rizzi; L Manzo; S M Candura; L Onori
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

10.  The role of the L-arginine/nitric oxide pathway for relaxation of the human lower oesophageal sphincter.

Authors:  A Tøttrup; L Ny; P Alm; B Larsson; A Forman; K E Andersson
Journal:  Acta Physiol Scand       Date:  1993-12
View more
  9 in total

1.  The esophagogastric junction.

Authors:  Larry S Miller; Anil K Vegesna; James G Brasseur; Alan S Braverman; Michael R Ruggieri
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

Review 2.  Physiology of the upper segment, body, and lower segment of the esophagus.

Authors:  Larry Miller; Pere Clavé; Ricard Farré; Begoña Lecea; Michael R Ruggieri; Ann Ouyang; Julie Regan; Barry P McMahon
Journal:  Ann N Y Acad Sci       Date:  2013-10       Impact factor: 5.691

3.  Enhanced nicotinic receptor mediated relaxations in gastroesophageal muscle fibers from Barrett's esophagus patients.

Authors:  L S Miller; A K Vegesna; A S Braverman; M F Barbe; M R Ruggieri
Journal:  Neurogastroenterol Motil       Date:  2013-12-15       Impact factor: 3.598

Review 4.  Nicotinic regulation of energy homeostasis.

Authors:  Michele Zoli; Marina R Picciotto
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

5.  Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.

Authors:  Zeljka Belosic Halle; Josipa Vlainic; Domagoj Drmic; Dean Strinic; Kresimir Luetic; Mario Sucic; Maria Medvidovic-Grubisic; Tatjana Pavelic Turudic; Igor Petrovic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

6.  Investigation of cholecystokinin receptors in the human lower esophageal sphincter.

Authors:  Jun-Feng Liu; Jian Zhang; Xin-Bo Liu; Paul A Drew
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Nicotinic receptor subtypes mediating relaxation of the normal human clasp and sling fibers of the upper gastric sphincter.

Authors:  M R Ruggieri; A S Braverman; A K Vegesna; L S Miller
Journal:  Neurogastroenterol Motil       Date:  2014-05-14       Impact factor: 3.598

8.  Functional morphology of the lower esophageal sphincter and crural diaphragm determined by three-dimensional high-resolution esophago-gastric junction pressure profile and CT imaging.

Authors:  Ravinder K Mittal; Ali Zifan; Dushyant Kumar; Melissa Ledgerwood-Lee; Erika Ruppert; Gary Ghahremani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-06-01       Impact factor: 4.052

9.  Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.

Authors:  Zeljko Djakovic; Ivka Djakovic; Vedran Cesarec; Goran Madzarac; Tomislav Becejac; Goran Zukanovic; Domagoj Drmic; Lovorka Batelja; Anita Zenko Sever; Danijela Kolenc; Alen Pajtak; Nikica Knez; Mladen Japjec; Kresimir Luetic; Dinko Stancic-Rokotov; Sven Seiwerth; Predrag Sikiric
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.